CAR-T Meeting 2023 | Improving CAR-T cell efficacy: optimizing CAR constructs and counteracting tumor escape
In this video, Sonia Guedan, PhD, IDIBAPS-Hospital Clinic Barcelona, Barcelona, Spain, briefly discusses strategies to improve CAR-T cell efficacy, highlighting the importance of optimizing CAR constructs and counteracting mechanisms of tumor escape. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
I am inventor on patents related to CAR-T cell therapy, filed by the University of Pennsylvania and licensed to Novartis and Tmunity Therapeutics. I have received commercial research funding from Gilead. I have received lecture fees from Bristol Myers-Squibb, Roche and Gilead.
